09.05.2024 13:07:51 - dpa-AFX: *MERCK: HEALTH CANADA APPROVES KEYTRUDA + GEMCITABINE-BASED CHEMOTHERAPY FOR BILIARY TRACT CARCINOMA IN ADULTS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
MERCK CO. DL-,01 A0YD8Q Xetra 122,000 28.06.24 16:03:09 +1,200 +0,99% 121,800 122,000 121,800 120,800

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH